Detalles de la búsqueda
1.
Is children's mental health an important function of newly national organization for health crisis management in Japan?
PCN Rep;
3(1): e175, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38868482
2.
Effects of Once-Weekly Semaglutide on Cardiovascular Risk Factors and Metabolic Dysfunction-Associated Steatotic Liver Disease in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study Based on Real-World Data.
Biomedicines;
12(5)2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38790963
3.
Renal Function Improvement With Glucagon-Like Peptide-1 Receptor Agonist in a Patient With Type 2 Diabetes.
J Med Cases;
15(2-3): 37-42, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38646419
4.
Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
J Diabetes Investig;
2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451108
5.
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.
Cells;
13(5)2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38474414
6.
Association between comorbidities associated with diabetes and higher-level functional status in older patients with type 2 diabetes mellitus: a cross sectional study.
Eur Geriatr Med;
2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340284
7.
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.
J Atheroscler Thromb;
31(6): 641-853, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123343
8.
Prescription of anti-influenza drugs in Japan, 2014-2020: A retrospective study using open data from the national claims database.
PLoS One;
18(10): e0291673, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37792686
9.
Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments.
Int J Mol Sci;
24(20)2023 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37895151
10.
Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments.
Int J Mol Sci;
24(18)2023 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37762244
11.
A Significant Effect of Pemafibrate on Hepatic Steatosis and Fibrosis Indexes in Patients With Hypertriglyceridemia.
Gastroenterology Res;
16(4): 240-243, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37691751
12.
Association of the use of psychotropic drugs with hospitalization, cardiovascular events, and mortality in patients with type 2 diabetes: a propensity score-matched cohort study.
Front Clin Diabetes Healthc;
4: 1181998, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37476651
13.
Significance of Endothelial Dysfunction Amelioration for Sodium-Glucose Cotransporter 2 Inhibitor-Induced Improvements in Heart Failure and Chronic Kidney Disease in Diabetic Patients.
Metabolites;
13(6)2023 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37367894
14.
Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications.
Biology (Basel);
12(5)2023 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37237539
15.
Measurement of cholesterol levels of lipoprotein subclasses in human serum using anion-exchange high-performance liquid chromatography with a linear concentration gradient of sodium perchlorate.
Ann Clin Biochem;
60(6): 374-385, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37194115
16.
A Possible Exquisite Crosstalk of Urate Transporter 1 With Other Urate Transporters for Chronic Kidney Disease and Cardiovascular Disease Induced by Dotinurad.
Cardiol Res;
14(2): 158-160, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37091888
17.
Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB-4 index in metabolic-associated fatty liver disease.
Hepatol Res;
53(7): 618-628, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905232
18.
Periodic health checkups reduce the risk of hospitalization in patients with type 2 diabetes.
Front Clin Diabetes Healthc;
4: 1087303, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36993816
19.
Real-World Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist, Dulaglutide, on Metabolic Parameters in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study.
Biomedicines;
11(3)2023 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36979848
20.
Glucagon-Like Peptide 1 Receptor Agonists Versus Sodium-Glucose Cotransporter 2 Inhibitors for Atherosclerotic Cardiovascular Disease in Patients With Type 2 Diabetes.
Cardiol Res;
14(1): 12-21, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36896226